AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence | Machine Learning | Natural Language Processing Ablacon | AI-guided Atrial Fibrillation Therapies.

Consumer, Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support Greater Denver Area, Western US, CO, United States

Artificial Intelligence | Machine Learning | Natural Language Processing

Ablacon | AI-guided Atrial Fibrillation Therapies.

Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support

Greater Denver Area, Western US, CO, United States

Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.

We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE).

Total Funding: $33.5M

Funding Stage: Series B

Business Stage: Development

Market: B2G, B2B

Company Size: 26 to 50

Founded: 2015

For AI Startup Founders

Get introduced to VC/PE/CVC investors

Get Started

For Investors at VC/PE firms

Get introduced to AI Startup founders or founders at Ablacon

Duke Rohlen
CEO

Josef Koblish
Chief Strategy Officer

Peter Ruppersberg
Chief Scientific Officer & President

Melissa Kong
Associate Medical Director

Ablacon - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups Ablacon - Manage Profile

World's Most Promising AI Startups

World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals

Get Started